225 related articles for article (PubMed ID: 21349950)
1. The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: a systematic review of literature.
van de Water TA; Bijl HP; Schilstra C; Pijls-Johannesma M; Langendijk JA
Oncologist; 2011; 16(3):366-77. PubMed ID: 21349950
[TBL] [Abstract][Full Text] [Related]
2. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA;
Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528
[TBL] [Abstract][Full Text] [Related]
3. Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer.
Moreno AC; Frank SJ; Garden AS; Rosenthal DI; Fuller CD; Gunn GB; Reddy JP; Morrison WH; Williamson TD; Holliday EB; Phan J; Blanchard P
Oral Oncol; 2019 Jan; 88():66-74. PubMed ID: 30616799
[TBL] [Abstract][Full Text] [Related]
4. Intensity modulated photon and proton therapy for the treatment of head and neck tumors.
Steneker M; Lomax A; Schneider U
Radiother Oncol; 2006 Aug; 80(2):263-7. PubMed ID: 16916557
[TBL] [Abstract][Full Text] [Related]
5. Treatment planning comparison for head and neck cancer between photon, proton, and combined proton-photon therapy - From a fixed beam line to an arc.
Amstutz F; Krcek R; Bachtiary B; Weber DC; Lomax AJ; Unkelbach J; Zhang Y
Radiother Oncol; 2024 Jan; 190():109973. PubMed ID: 37913953
[TBL] [Abstract][Full Text] [Related]
6. A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours.
Cozzi L; Fogliata A; Lomax A; Bolsi A
Radiother Oncol; 2001 Dec; 61(3):287-97. PubMed ID: 11730999
[TBL] [Abstract][Full Text] [Related]
7. Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison.
Kandula S; Zhu X; Garden AS; Gillin M; Rosenthal DI; Ang KK; Mohan R; Amin MV; Garcia JA; Wu R; Sahoo N; Frank SJ
Med Dosim; 2013; 38(4):390-4. PubMed ID: 23916884
[TBL] [Abstract][Full Text] [Related]
8. Impact of interfractional changes in head and neck cancer patients on the delivered dose in intensity modulated radiotherapy with protons and photons.
Müller BS; Duma MN; Kampfer S; Nill S; Oelfke U; Geinitz H; Wilkens JJ
Phys Med; 2015 May; 31(3):266-72. PubMed ID: 25724350
[TBL] [Abstract][Full Text] [Related]
9. Protons in head-and-neck cancer: bridging the gap of evidence.
Ramaekers BL; Grutters JP; Pijls-Johannesma M; Lambin P; Joore MA; Langendijk JA
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1282-8. PubMed ID: 23273998
[TBL] [Abstract][Full Text] [Related]
10. Dose planning study of proton versus photon radiotherapy for head and neck squamous cell carcinoma of unknown primary in the primary and recurrent setting.
Holm AIS; Elstrøm UV; Nielsen SB; Jensen K
Acta Oncol; 2023 Nov; 62(11):1412-1417. PubMed ID: 37815913
[TBL] [Abstract][Full Text] [Related]
11. Considerations for study design in the DAHANCA 35 trial of protons versus photons for head and neck cancer.
Friborg J; Jensen K; Eriksen JG; Samsøe E; Maare C; Farhadi M; Sibolt P; Nielsen M; Andersen M; Holm AIS; Skyt P; Smulders B; Johansen J; Overgaard J; Grau C; Hansen CR
Radiother Oncol; 2024 Jan; 190():109958. PubMed ID: 37871751
[TBL] [Abstract][Full Text] [Related]
12. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.
Baumert BG; Norton IA; Lomax AJ; Davis JB
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1314-24. PubMed ID: 15519805
[TBL] [Abstract][Full Text] [Related]
13. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
Weber DC; Trofimov AV; Delaney TF; Bortfeld T
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated proton therapy (IMPT) versus intensity-modulated radiation therapy (IMRT) for the treatment of head and neck cancer: A dosimetric comparison.
Nguyen ML; Cantrell JN; Ahmad S; Henson C
Med Dosim; 2021 Autumn; 46(3):259-263. PubMed ID: 33648823
[TBL] [Abstract][Full Text] [Related]
15. Cone beam CT-based adaptive intensity modulated proton therapy assessment using automated planning for head-and-neck cancer.
Xu Y; Jin W; Butkus M; De Ornelas M; Cyriac J; Studenski MT; Padgett K; Simpson G; Samuels S; Samuels M; Dogan N
Radiat Oncol; 2024 Jan; 19(1):13. PubMed ID: 38263237
[TBL] [Abstract][Full Text] [Related]
16. NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.
Jakobi A; Stützer K; Bandurska-Luque A; Löck S; Haase R; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
Acta Oncol; 2015; 54(9):1658-64. PubMed ID: 26340301
[TBL] [Abstract][Full Text] [Related]
17. Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicentric in silico ROCOCO trial.
Eekers DBP; Roelofs E; Jelen U; Kirk M; Granzier M; Ammazzalorso F; Ahn PH; Janssens GORJ; Hoebers FJP; Friedmann T; Solberg T; Walsh S; Troost EGC; Kaanders JHAM; Lambin P
Radiother Oncol; 2016 Dec; 121(3):387-394. PubMed ID: 27639891
[TBL] [Abstract][Full Text] [Related]
18. Robust Intensity Modulated Proton Therapy (IMPT) Increases Estimated Clinical Benefit in Head and Neck Cancer Patients.
van Dijk LV; Steenbakkers RJ; ten Haken B; van der Laan HP; van 't Veld AA; Langendijk JA; Korevaar EW
PLoS One; 2016; 11(3):e0152477. PubMed ID: 27030987
[TBL] [Abstract][Full Text] [Related]
19. Systematic review and meta-analysis of radiotherapy in various head and neck cancers: comparing photons, carbon-ions and protons.
Ramaekers BL; Pijls-Johannesma M; Joore MA; van den Ende P; Langendijk JA; Lambin P; Kessels AG; Grutters JP
Cancer Treat Rev; 2011 May; 37(3):185-201. PubMed ID: 20817407
[TBL] [Abstract][Full Text] [Related]
20. Identification of Patient Benefit From Proton Therapy for Advanced Head and Neck Cancer Patients Based on Individual and Subgroup Normal Tissue Complication Probability Analysis.
Jakobi A; Bandurska-Luque A; Stützer K; Haase R; Löck S; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1165-1174. PubMed ID: 26194685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
